These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 32606740

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm.
    Lee SS, McCue D, Pemmaraju N.
    Expert Rev Anticancer Ther; 2020 Jul; 20(7):543-550. PubMed ID: 32460559
    [Abstract] [Full Text] [Related]

  • 3. Tagraxofusp, a novel CD123-directed cytotoxin to treat blastic plasmacytoid dendritic cell neoplasm.
    Tandon A, Zhang Y, Sokol L.
    Drugs Today (Barc); 2019 Dec; 55(12):735-742. PubMed ID: 31942876
    [Abstract] [Full Text] [Related]

  • 4. Tagraxofusp and anti-CD123 in blastic plasmacytoid dendritic cell neoplasm: a new hope.
    Cangini D, Silimbani P, Cafaro A, Giannini MB, Masini C, Ghelli Luserna Di Rorà A, Simonetti G, Martinelli G, Cerchione C.
    Minerva Med; 2020 Oct; 111(5):467-477. PubMed ID: 32955827
    [Abstract] [Full Text] [Related]

  • 5. Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm.
    Economides MP, McCue D, Lane AA, Pemmaraju N.
    Expert Rev Clin Pharmacol; 2019 Oct; 12(10):941-946. PubMed ID: 31465247
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relapse of tagraxofusp treated blastic plasmacytoid dendritic cell neoplasm with loss of CD123 expression.
    Gulati R, Abu-Salah A, Salous T, Nassiri M.
    J Hematop; 2022 Mar; 15(1):35-39. PubMed ID: 38358597
    [Abstract] [Full Text] [Related]

  • 9. Targeting CD123 in BPDCN: an emerging field.
    DiPippo AJ, Wilson NR, Pemmaraju N.
    Expert Rev Hematol; 2021 Nov; 14(11):993-1004. PubMed ID: 34607517
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tagraxofusp in myeloid malignancies.
    Bruzzese A, Martino EA, Labanca C, Mendicino F, Lucia E, Olivito V, Neri A, Imovilli A, Morabito F, Vigna E, Gentile M.
    Hematol Oncol; 2024 Jan; 42(1):e3234. PubMed ID: 37846131
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm.
    Pemmaraju N, Konopleva M.
    Blood Adv; 2020 Aug 25; 4(16):4020-4027. PubMed ID: 32841341
    [Abstract] [Full Text] [Related]

  • 14. Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm.
    Economides MP, Konopleva M, Pemmaraju N.
    Ther Adv Hematol; 2019 Aug 25; 10():2040620719874733. PubMed ID: 31579499
    [Abstract] [Full Text] [Related]

  • 15. Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm.
    Luskin MR, Lane AA.
    Haematologica; 2024 Jan 01; 109(1):44-52. PubMed ID: 36951152
    [Abstract] [Full Text] [Related]

  • 16. Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN).
    Wilson NR, Pemmaraju N.
    Expert Opin Pharmacother; 2022 Mar 01; 23(4):431-438. PubMed ID: 35060807
    [Abstract] [Full Text] [Related]

  • 17. Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Pemmaraju N, Deconinck E, Mehta P, Walker I, Herling M, Garnache-Ottou F, Gabarin N, Campbell CJV, Duell J, Moshe Y, Mughal T, Mohty M, Angelucci E.
    Clin Lymphoma Myeloma Leuk; 2024 Apr 01; 24(4):e130-e137. PubMed ID: 38267355
    [Abstract] [Full Text] [Related]

  • 18. Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN).
    Alfayez M, Konopleva M, Pemmaraju N.
    Expert Opin Biol Ther; 2020 Feb 01; 20(2):115-123. PubMed ID: 31801379
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.